Pharmaceutical industry

The pharmaceutical industry is one of the world’s most important sectors and is characterized by complex manufacturing processes and high quality standards. Our experience enables us to handle the demanding conditions that may arise in different production processes. Emission-control systems must be designed to accommodate possible concentration peaks and aggressive substances in the exhaust gas.

Emission control technologies for the pharmaceutical industry:

Regenerative Catalytic Oxidation (RCO)

RCO is ideal for operations with a defined pollutant composition and low to medium concentrations of volatile organic compounds (VOCs). The catalyst enables oxidation at lower temperatures, which is beneficial where temperature-sensitive or aggressive substances are present. It also prevents the formation of undesirable by-products such as nitrogen oxides (NOx).

Regenerative Thermal Oxidation (RTO)

RTO is suitable for a broad range of pollutants and can handle high VOC concentrations, including sudden peaks. The exhaust gas passes through a ceramic heat-storage bed into the oxidation chamber, where VOCs are oxidized at high temperatures. The system is resistant to aggressive substances and provides high emission-removal efficiency (> 99%).

Activated Carbon Adsorber

For small and medium air volumes with low VOC concentrations, an activated carbon adsorber is a cost-effective solution. Activated carbon efficiently captures VOCs and can be periodically regenerated, allowing continuous operation with low running costs.

Examples of pharmaceutical-industry applications:

Active pharmaceutical ingredient production: The synthesis of active ingredients generates VOCs and other pollutants. RCO or RTO systems can remove these emissions efficiently and handle sudden concentration increases caused by irregular production cycles.
Drying and granulation: Activated carbon adsorbers are suitable for removing VOCs from granule and powder drying processes with low VOC concentrations and medium air volumes.
Production of injectable solutions and ointments: RCO technology removes VOC emissions from mixing and filling processes while accommodating sensitive substances.

Benefits of implementing these technologies:

Compliance with stringent emission limits: The pharmaceutical industry is subject to strict regulatory requirements, making effective emission control essential.
Safety and health protection: Removing harmful substances improves the working environment and protects employees and nearby communities.
Resistance to aggressive substances: Our equipment is designed to withstand aggressive chemicals in exhaust gases, ensuring long service life and reliable operation.
Energy efficiency: Technologies such as RCO save energy through lower operating temperatures, reducing operating costs.

Our individual approach and in-depth industry expertise enable us to design and implement optimal pharmaceutical emission-control solutions that address the specific needs and challenges of your operation.